"Anemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Descriptor ID |
D000740
|
| MeSH Number(s) |
C15.378.071
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Anemia".
Below are MeSH descriptors whose meaning is more specific than "Anemia".
This graph shows the total number of publications written about "Anemia" by people in this website by year, and whether "Anemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 0 | 2 | 2 |
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 3 | 4 |
| 1998 | 2 | 0 | 2 |
| 1999 | 1 | 3 | 4 |
| 2000 | 3 | 1 | 4 |
| 2001 | 4 | 5 | 9 |
| 2002 | 10 | 4 | 14 |
| 2003 | 5 | 9 | 14 |
| 2004 | 5 | 1 | 6 |
| 2005 | 6 | 5 | 11 |
| 2006 | 5 | 7 | 12 |
| 2007 | 12 | 6 | 18 |
| 2008 | 10 | 2 | 12 |
| 2009 | 7 | 7 | 14 |
| 2010 | 9 | 7 | 16 |
| 2011 | 10 | 7 | 17 |
| 2012 | 7 | 4 | 11 |
| 2013 | 8 | 7 | 15 |
| 2014 | 12 | 9 | 21 |
| 2015 | 6 | 6 | 12 |
| 2016 | 11 | 7 | 18 |
| 2017 | 10 | 11 | 21 |
| 2018 | 11 | 5 | 16 |
| 2019 | 8 | 4 | 12 |
| 2020 | 9 | 6 | 15 |
| 2021 | 16 | 5 | 21 |
| 2022 | 28 | 0 | 28 |
| 2023 | 22 | 1 | 23 |
| 2024 | 7 | 0 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anemia" by people in Profiles.
-
Safety and efficacy of luspatercept for the treatment of anemia in?patients with myelofibrosis. Blood Adv. 2024 Sep 10; 8(17):4511-4522.
-
Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study. Haematologica. 2024 08 01; 109(8):2660-2664.
-
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial. Lancet Haematol. 2024 Sep; 11(9):e646-e658.
-
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study. Lancet Oncol. 2024 Apr; 25(4):488-500.
-
Etiologies and Outcomes of Normocytic Anemia in Children. J Pediatr. 2024 Aug; 271:114041.
-
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial. Lancet. 2024 Apr 13; 403(10435):1460-1471.
-
Increased iron uptake by splenic hematopoietic stem cells promotes TET2-dependent erythroid regeneration. Nat Commun. 2024 Jan 15; 15(1):538.
-
Intravenous iron therapy in pediatrics: who should get it and when is the right time? Hematology Am Soc Hematol Educ Program. 2023 Dec 08; 2023(1):630-635.
-
Reticulocyte hemoglobin equivalent as a marker to assess iron deficiency: A large pediatric tertiary care hospital study. Int J Lab Hematol. 2024 Feb; 46(1):148-155.
-
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis. Blood Adv. 2023 10 10; 7(19):5835-5842.